- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Hormone Dependent Prostate Cancer
Total 14785 results
-
Ferring PharmaceuticalsCompletedAdvanced Hormone Dependent Prostate CancerArgentina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer | Hormone-Dependent Prostate CancerChina, Czechia, Poland, Bulgaria
-
Ferring PharmaceuticalsCompletedAdvanced Hormone Sensitive Prostate CancerNetherlands
-
RenJi HospitalNot yet recruitingProstate Cancer | Chemotherapy Effect | Hormone Sensitive Prostate Cancer | Locally Advanced Prostate Carcinoma
-
IpsenActive, not recruitingMetastatic Prostate Cancer | Advanced Prostate Cancer | Locally Advanced Prostate CancerChina
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Ferring PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
University of Turin, ItalyUnknownAdvanced Prostate CancerItaly
-
AstraZenecaCompletedAdvanced Prostate CancerCroatia
-
AstraZenecaActive, not recruitingAdvanced Prostate CancerChina
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
Ferring PharmaceuticalsFerring Arzneimittel GmbHCompletedAndrogen Ablative Therapy of Advanced Hormone-dependent Prostate CarcinomaGermany
-
GenVecNational Institutes of Health (NIH)UnknownLocally Advanced Prostate CancerUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
Turku University HospitalUniversity of TurkuActive, not recruitingBenign Prostatic Hyperplasia | Locally Advanced Prostate Cancer | Locally Recurrent Prostate Cancer | Localised Prostate CancerFinland
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Active, not recruiting
-
Centro Nacional de Investigaciones Oncologicas...UnknownAdvanced Prostate Cancer | Docetaxel | CabazitaxelSpain
-
Centro Nacional de Investigaciones Oncologicas...UnknownAdvanced Prostate Cancer | Abiraterone ACetateSpain
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | EnzalutamideSpain
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | Radium 223Spain
-
IpsenCompletedAdvanced Prostate CancerNetherlands, France, United Kingdom, Denmark, Latvia, Lithuania, Romania
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
AstraZenecaCompletedAdvanced Prostate AdenocarcinomaUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
The First Affiliated Hospital of Xiamen UniversityRecruitingOligometastatic Prostate Cancer | Locally Advanced Prostate CancerChina
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Institut Paoli-CalmettesTerminatedAndrogen-independent Prostate CancerFrance
-
AstraZenecaCompletedLocally Advanced Prostate CancerNorway
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Cliniques universitaires Saint-Luc- Université...SanofiCompletedMetastatic Prostate Cancer | Hormone Resistant Prostate CancerBelgium, Luxembourg
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Hormone-Resistant Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedEnzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Mayo ClinicCompletedProstate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminatedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States